## Use of MMSE to differentiate Alzheimer's disease from dementia with Lewy bodies Dear Editor Like Dr Ala and his colleagues (Ala et al., 2002), we have encountered patients with pathologically confirmed dementia with Lewy bodies (DLB) who retro-spectively scored < 5 on the Ala MMSE subscore test
Use of MMSE to differentiate Alzheimer's disease from dementia with Lewy bodies
β Scribed by A. J. Larner
- Publisher
- John Wiley and Sons
- Year
- 2004
- Tongue
- English
- Weight
- 38 KB
- Volume
- 19
- Category
- Article
- ISSN
- 0885-6230
- DOI
- 10.1002/gps.1189
No coin nor oath required. For personal study only.
β¦ Synopsis
Use of MMSE to differentiate Alzheimer's disease from dementia with Lewy bodies Dear Editor
Like Dr Ala and his colleagues (Ala et al., 2002), we have encountered patients with pathologically confirmed dementia with Lewy bodies (DLB) who retro-spectively scored < 5 on the Ala MMSE subscore test (Doran and Larner, 2004, case 1). Hence, like them, we have hoped that this might be a useful diagnostic test for DLB and might assist in the differential diagnosis of DLB from Alzheimer's disease (AD).
π SIMILAR VOLUMES
## Abstract ## Objective Dementia with Lewy bodies (DLB) is the second most common neurodegenerative dementia, but it is often underdiagnosed and mistaken for Alzheimer's disease (AD) with sometimes lethal consequences. Over 35 studies have established the differences between DLB and AD in neurops
Dear Editor ΓΎ p < 0.01 as compared with the DLB group. # p < 0.01 as compared with the AD group.
## Abstract ## Objective To demonstrate the exact nature of the cognitive profile of dementia with Lewy bodies (DLB) on standardized neuropsychological tests including the Wechsler Adult Intelligence ScaleββRevised (WAISβR) and the Wechsler Memory ScaleββRevised (WMSβR). ## Design We examined th
## Abstract ## Background Little is known about the rate of progression or associations of cognitive impairment in dementia with Lewy bodies (DLB), or the associations of accelerated decline. ## Method Dementia patients from a case register were evaluated at baseline and 1 year followβup using t
## Abstract Seeking antemortem markers to distinguish Dementia with Lewy bodies (DLB) and Alzheimer's disease (AD), we examined brain glucose metabolism of DLB and AD. Eleven DLB patients (7 Lewy body variant of AD [LBVAD] and 4 pure diffuse Lewy body disease [DLBD]) who had antemortem position emi